Rockwell Medical Announces 2024 Annual Meeting of Stockholders on May 21, 2024

TL;DR

**Rockwell Medical will hold its 2024 Annual Meeting of Stockholders virtually on May 21, 2024, to vote on director elections, executive compensation, and auditor ratification.**

AI Summary

ROCKWELL MEDICAL, INC. (RMTI) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. The 2024 Annual Meeting of Stockholders for Rockwell Medical, Inc. will be held virtually on May 21, 2024, at 10:00 a.m. Eastern Time. Stockholders will vote on electing two Class III directors for three-year terms, approving executive compensation on an advisory basis, and ratifying EisnerAmper LLP as the independent auditor for 2024. The record date for stockholders entitled to notice and voting is March 25, 2024. The meeting will be conducted online at www.virtualshareholdermeeting.com/RMTI2024, allowing attendees to vote and submit questions. The proxy statement is filed under Schedule 14A, indicating it's a definitive proxy statement related to the annual meeting. The company's central index key is 0001041024 and its SIC code is 2834 (Pharmaceutical Preparations).

Why It Matters

For investors and stakeholders tracking ROCKWELL MEDICAL, INC., this filing contains several important signals. The meeting agenda includes key corporate governance decisions such as director elections and advisory approval of executive compensation, which directly impact the company's leadership and financial stewardship. Ratifying the independent auditor, EisnerAmper LLP, is crucial for maintaining financial transparency and investor confidence in the company's reported financial statements.

Risk Assessment

Risk Level: — ROCKWELL MEDICAL, INC. shows moderate risk based on this filing. The filing is a routine proxy statement (DEF 14A) detailing the agenda for the annual shareholder meeting, with no new financial or operational disclosures that would indicate immediate risk.

Analyst Insight

Stockholders should review the proxy materials carefully before the May 21, 2024 meeting to make informed voting decisions on director nominees, executive compensation, and auditor ratification.

Key Numbers

• 2024-05-21 — Annual Meeting Date (Date of the 2024 Annual Meeting of Stockholders)
• 2024-03-25 — Record Date (Date for determining stockholders entitled to vote)
• 2027 — Director Term Expiration (Year director terms expire)
• 10:00 a.m. Eastern Time — Meeting Time (Time of the virtual Annual Meeting)

Key Players & Entities

• ROCKWELL MEDICAL, INC. (company) — Registrant
• EisnerAmper LLP (company) — independent registered public accounting firm
• May 21, 2024 (date) — 2024 Annual Meeting of Stockholders date
• March 25, 2024 (date) — record date for stockholders
• www.virtualshareholdermeeting.com/RMTI2024 (url) — online meeting platform
• Class III directors (other) — directors to be elected
• 2027 annual meeting (date) — director term expiration
• Schedule 14A (other) — Filing type

FAQ

Risk Factors

• Filing Requirements [low — regulatory]: The company must comply with SEC regulations for proxy statements, including providing detailed information on matters to be voted upon by shareholders.
• Auditor Ratification [low — financial]: Shareholders will vote on ratifying EisnerAmper LLP as the independent registered public accounting firm for 2024, a standard procedure to ensure financial oversight.
• Director Elections [low — governance]: Two Class III directors will be elected to serve three-year terms, a key component of corporate governance and board composition.
• Executive Compensation Approval [low — governance]: Shareholders will provide an advisory vote on the compensation of named executive officers, reflecting shareholder sentiment on pay practices.

Industry Context

Rockwell Medical, Inc. operates in the pharmaceutical preparations industry, focusing on products related to dialysis and other medical treatments.

Regulatory Implications

The company is subject to the Securities Exchange Act of 1934, specifically Section 14(a) and Regulation 14A, which govern the solicitation of proxies for shareholder meetings.

What Investors Should Do

1. Review the proxy statement for details on director nominees and their qualifications.
2. Evaluate the advisory vote on executive compensation to understand the company's pay practices.
3. Confirm the ratification of EisnerAmper LLP as the independent auditor for 2024.

Key Dates

• 2024-05-21: 2024 Annual Meeting of Stockholders — Key date for voting on corporate matters.
• 2024-03-25: Record Date — Determines which stockholders are eligible to vote at the Annual Meeting.

Year-Over-Year Comparison

This filing is a DEF 14A, a definitive proxy statement, which is a standard disclosure for annual shareholder meetings and does not represent a change from previous filings in terms of its nature, but rather provides updated information for the current year's meeting.

Key Financial Figures

• $0.0001 — f record of our common stock, par value $0.0001 per share, which we refer to as our com
• $6,500 — on with the Annual Meeting at a cost of $6,500 plus reasonable out-of-pocket expenses.

Filing Documents

• ny20019207x1_def14a.htm (DEF 14A) — 621KB
• logo_rockwellmedical.jpg (GRAPHIC) — 49KB
• ny20019207x1_pvp01.jpg (GRAPHIC) — 150KB
• ny20019207x1_pvp02.jpg (GRAPHIC) — 215KB
• ny20019207x1_pc01.jpg (GRAPHIC) — 615KB
• ny20019207x1_pc02.jpg (GRAPHIC) — 667KB
• 0001140361-24-019847.txt ( ) — 2956KB

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT ​ ​ 31 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS ​ ​ 32 OTHER MATTERS ​ ​ 33 i TABLE OF CONTENTS QUESTIONS AND ANSWERS Why am I receiving these proxy materials? You are receiving these proxy materials, including this Proxy Statement, the Notice of the 2024 Annual Meeting of Stockholders, the 2023 Annual Report and the proxy card or voting instruction form, in connection with the solicitation of proxies by the Board for use at the Annual Meeting to be held on May 21, 2024 at 10:00 a.m. Eastern Time, and all adjournments or postponements thereof. The Annual Meeting will be held as a virtual (online) meeting. You may attend the Annual Meeting, vote and submit a question during the meeting by visiting www.virtualshareholdermeeting.com/RMTI2024 . Who is entitled to vote at the Annual Meeting? Only stockholders of record of our common stock, par value $0.0001 per share, which we refer to as our common stock, at the close of business on March 25, 2024, the record date for the Annual Meeting, will be entitled to notice of, and to vote at, the Annual Meeting or any adjournment or postponement thereof. As of the close of business on the record date, we had 29,364,617 shares of common stock outstanding, the only class of stock outstanding and entitled to vote. Each share of common stock is entitled to one vote on each matter submitted for a vote at the Annual Meeting. The presence, in person or by proxy, of the holders of record of a majority of the outstanding shares of common stock entitled to vote is necessary to constitute a quorum for the transaction of business at the Annual Meeting or any adjournment or postponement thereof. Abstentions and broker non-votes will be counted toward the quorum requirement. Valid proxies in the enclosed form which are timely returned and executed and dated in accordance with the instructions on

View Full Filing

View this DEF 14A filing on SEC EDGAR